During our research, we identified close to 85 players that are engaged in supplying biopharmaceutical filtration systems. 

Majority of the biopharmaceutical filtration system suppliers are headquartered in North America; all of these players have their headquarters in the US. This is followed by players based in Europe. Within this region, maximum number of players are headquartered in France, Germany, Switzerland, Italy and UK. Further, over the past few years, several biopharmaceutical filtration system suppliers have established their foothold in the Asia-Pacific region as well.

Request a sample copy of the Global Filtration Market report

https://www.rootsanalysis.com/reports/global-filtration-market/request-sample.html

Majority (82%) of the suppliers offer membrane filters. This can be attributed to the fact that these are widely used in biopharmaceutical manufacturing for sterile filtration and virus filtration due to their high efficiency, durability, and versatility. This is followed by tangential flow filters (43%) and depth filters (32%). It is worth highlighting that virus filtration is an emerging technique, which is being offered by various suppliers across the globe.

Majority of the suppliers that offer virus filtration systems are headquartered in Europe and Asia-Pacific, followed by North America. Further, in terms of technological advancements, 3M and Cole-Parmer offer chromatography filters and Repligen offers tangential flow depth filtration systems. These filters are revolutionizing the biopharmaceutical filtration industry by streamlining the upstream processes and simplifying and intensifying processing of biologics.

The Global Filtration industry has witnessed the entry of more than 35% players, post 2000, indicating the growing interest of stakeholders in this domain. Examples of some recently established players include (established post-20010, in reverse chronological order, in alphabetical order) Bio-Link (2021), Filtravate (2020), 4th Phase Water Technologies (2017), Guochu Technology (2016) and Hangzhou Guidling Technology (2016). This is followed by players established between 1950 and 2000 (35%).

It is evident from the figure that companies offering biopharmaceutical filtration systems have been segregated under three categories, namely small (less than 50 employees), mid-sized (51-500 employees) and large companies (more than 500 employees). Majority (18%) of the players based in North America are mid-sized companies, followed by large (17%) and small companies (11%), whereas an equal number of large and small companies (11%, each) are based in Europe. Examples of mid-sized players based in North America include (offering more than three types of filtration systems, in alphabetical order) Agilitech and The Strainrite Companies. Further, it is worth highlighting that Asia-Pacific is also dominated by mid-sized players (16%). It is important to mention that, for the purpose of this analysis, information has been sourced primarily from company websites and other reliable sources, such as LinkedIn.

Moreover, close to 80% of the players offer filtration systems that can efficiently perform cells separation / product purification, followed by players that have ability to offer cell culture clarification, sterilization and viral clearance (72%, 47% and 35% respectively). Further, over 15% of biopharmaceutical filtration system suppliers have the capability to collectively provide filtration systems for cells separation / product purification, cell culture clarification, sterilization and viral clearance. Examples of some companies offering filtration systems for all four applications include (headquartered in North America, in alphabetical order) 3M, Critical Process Filtration, Cytiva, Membrane Solutions, Pall, Sterlitech and The Strainrite Companies.

Get more details on the Global Filtration Market report

https://www.rootsanalysis.com/reports/global-filtration-market.html

You may also be interested in the following titles:

DNA Encoded Libraries

Quantum Computing in Drug Discovery Services Market

You may also like to learn what our experts are sharing in Roots educational series:

Demand for Outsourcing Biologics Fill Finish Services

The Future of Dentistry: Dental 3D Printing

About Roots Analysis

Roots Analysis  is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com